Summary
Nicotinic acetylcholine receptors (nAChRs) regulate pain pathways with various outcomes depending on receptor subtypes, neuron types, and locations. But it remains unknown whether α4β2 nAChRs abundantly expressed in the substantia nigra pars reticulata (SNr) have potential to mitigate hyperalgesia in pain states. We observed that injection of nAChR antagonists into the SNr reduced pain thresholds in naïve mice, whereas injection of nAChR agonists into the SNr relieved hyperalgesia in mice, subjected to capsaicin injection into the lower hind leg, spinal nerve injury, chronic constriction injury, or chronic nicotine exposure. The analgesic effects of nAChR agonists were mimicked by optogenetic stimulation of cholinergic inputs from the pedunculopontine nucleus (PPN) to the SNr, but attenuated upon downregulation of α4 nAChRs on SNr GABAergic neurons and injection of dihydro-β-erythroidine into the SNr. Chronic nicotine-induced hyperalgesia depended on α4 nAChRs in SNr GABAergic neurons and was associated with the reduction of ACh release in the SNr. Either activation of α4 nAChRs in the SNr or optogenetic stimulation of the PPN-SNr cholinergic projection mitigated chronic nicotine-induced hyperalgesia. Interestingly, mechanical stimulation-induced ACh release was significantly attenuated in mice subjected to either capsaicin injection into the lower hind leg or SNI. These results suggest that α4 nAChRs on GABAergic neurons mediate a cholinergic analgesic circuit in the SNr, and these receptors may be effective therapeutic targets to relieve hyperalgesia in acute and chronic pain, and chronic nicotine exposure.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Busse JW, Wang L, Kamaleldin M, Craigie S, Riva JJ, Montoya L, et al. Opioids for chronic noncancer pain: a systematic review and meta-analysis. JAMA. 2018;320:2448–60.
Hylands-White N, Duarte RV, Raphael JH. An overview of treatment approaches for chronic pain management. Rheumatol Int. 2017;37:29–42.
Noori A, Sadeghirad B, Wang L, Siemieniuk RAC, Shokoohi M, Kum E, et al. Comparative benefits and harms of individual opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised trials. Br J Anaesth. 2022;129:394–406.
Higgins C, Smith BH, Matthews K. Evidence of opioid-induced hyperalgesia in clinical populations after chronic opioid exposure: a systematic review and meta-analysis. Br J Anaesth. 2019;122:e114–e26.
Koller G, Schwarzer A, Halfter K, Soyka M. Pain management in opioid maintenance treatment. Expert Opin Pharmacother. 2019;20:1993–2005.
Noori SA, Aiyer R, Yu J, White RS, Mehta N, Gulati A. Nonopioid versus opioid agents for chronic neuropathic pain, rheumatoid arthritis pain, cancer pain and low back pain. Pain Manag. 2019;9:205–16.
Dulawa SC, Janowsky DS. Cholinergic regulation of mood: from basic and clinical studies to emerging therapeutics. Mol Psychiatry. 2019;24:694–709.
Naser PV, Kuner R. Molecular, cellular and circuit basis of cholinergic modulation of pain. Neuroscience. 2018;387:135–48.
Schechtmann G, Song Z, Ultenius C, Meyerson BA, Linderoth B. Cholinergic mechanisms involved in the pain relieving effect of spinal cord stimulation in a model of neuropathy. Pain. 2008;139:136–45.
Umana IC, Daniele CA, McGehee DS. Neuronal nicotinic receptors as analgesic targets: it’s a winding road. Biochem Pharmacol. 2013;86:1208–14.
Umana IC, Daniele CA, Miller BA, Abburi C, Gallagher K, Brown MA, et al. Nicotinic modulation of descending pain control circuitry. Pain. 2017;158:1938–50.
Ji YW, Shen ZL, Zhang X, Zhang K, Jia T, Xu X, et al. Plasticity in ventral pallidal cholinergic neuron-derived circuits contributes to comorbid chronic pain-like and depression-like behaviour in male mice. Nat Commun. 2023;14:2182.
Marks MJ, Grady SR, Salminen O, Paley MA, Wageman CR, McIntosh JM, et al. α6β2*-subtype nicotinic acetylcholine receptors are more sensitive than α4β2*-subtype receptors to regulation by chronic nicotine administration. J Neurochem. 2014;130:185–98.
Tapper AR, McKinney SL, Nashmi R, Schwarz J, Deshpande P, Labarca C, et al. Nicotine activation of α4* receptors: sufficient for reward, tolerance, and sensitization. Science. 2004;306:1029–32.
Wooltorton JR, Pidoplichko VI, Broide RS, Dani JA. Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas. J Neurosci. 2003;23:3176–85.
Wu J. Understanding of nicotinic acetylcholine receptors. Acta Pharmacol Sin. 2009;30:653–5.
Xiao C, Zhou CY, Jiang JH, Yin C. Neural circuits and nicotinic acetylcholine receptors mediate the cholinergic regulation of midbrain dopaminergic neurons and nicotine dependence. Acta Pharmacol Sin. 2020;41:1–9.
Nashmi R, Xiao C, Deshpande P, McKinney S, Grady SR, Whiteaker P, et al. Chronic nicotine cell specifically upregulates functional α4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path. J Neurosci. 2007;27:8202–18.
Buisson B, Bertrand D. Chronic exposure to nicotine upregulates the human α4β2 nicotinic acetylcholine receptor function. J Neurosci. 2001;21:1819–29.
McGranahan TM, Patzlaff NE, Grady SR, Heinemann SF, Booker TK. α4β2 nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief. J Neurosci. 2011;31:10891–902.
Picciotto MR, Zoli M, Rimondini R, Lena C, Marubio LM, Pich EM, et al. Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine. Nature. 1998;391:173–7.
Xiao C, Nashmi R, McKinney S, Cai H, McIntosh JM, Lester HA. Chronic nicotine selectively enhances α4β2* nicotinic acetylcholine receptors in the nigrostriatal dopamine pathway. J Neurosci. 2009;29:12428–39.
Champtiaux N, Gotti C, Cordero-Erausquin M, David DJ, Przybylski C, Lena C, et al. Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice. J Neurosci. 2003;23:7820–9.
Klink R, de Kerchove d’Exaerde A, Zoli M, Changeux JP. Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J Neurosci. 2001;21:1452–63.
Estakhr J, Abazari D, Frisby K, McIntosh JM, Nashmi R. Differential control of dopaminergic excitability and locomotion by cholinergic inputs in mouse substantia nigra. Curr Biol. 2017;27:1900–14.e4.
Metaxas A, Bailey A, Barbano MF, Galeote L, Maldonado R, Kitchen I. Differential region-specific regulation of α4β2* nAChRs by self-administered and non-contingent nicotine in C57BL/6J mice. Addict Biol. 2010;15:464–79.
Miwa JM, Freedman R, Lester HA. Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses. Neuron. 2011;70:20–33.
Yin C, Jia T, Luan Y, Zhang X, Xiao C, Zhou C. A nigra-subthalamic circuit is involved in acute and chronic pain states. Pain. 2022;163:1952–66.
Jia T, Wang YD, Chen J, Zhang X, Cao JL, Xiao C, et al. A nigro-subthalamo-parabrachial pathway modulates pain-like behaviors. Nat Commun. 2022;13:7756.
WHO report on the global tobacco epidemic 2021: addressing new and emerging products. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO.
Wipfli H, Samet JM. One hundred years in the making: the global tobacco epidemic. Annu Rev Public Health. 2016;37:149–66.
De Biasi M, Dani JA. Reward, addiction, withdrawal to nicotine. Annu Rev Neurosci. 2011;34:105–30.
Wu J. Double target concept for smoking cessation. Acta Pharmacol Sin. 2010;31:1015–8.
Anderson KL, Pinkerton KE, Uyeminami D, Simons CT, Carstens MI, Carstens E. Antinociception induced by chronic exposure of rats to cigarette smoke. Neurosci Lett. 2004;366:86–91.
Shi Y, Weingarten TN, Mantilla CB, Hooten WM, Warner DO. Smoking and pain: pathophysiology and clinical implications. Anesthesiology. 2010;113:977–92.
Alfonso-Rodriguez J, Wang S, Zeng X, Candiotti KA, Zhang Y. Mechanism of electroacupuncture analgesia on nicotine withdrawal-induced hyperalgesia in a rat model. Evid Based Complement Altern Med. 2022;2022:7975803.
Luan Y, Tang D, Wu H, Gu W, Wu Y, Cao JL, et al. Reversal of hyperactive subthalamic circuits differentially mitigates pain hypersensitivity phenotypes in parkinsonian mice. Proc Natl Acad Sci USA. 2020;117:10045–54.
Paxinos G, Franklin KBJ. The mouse brain in stereotaxic coordinates. 2nd, Editor. (Academic Press, San Diego, 2001).
Wang D, Liu P, Mao X, Zhou Z, Cao T, Xu J, et al. Task-demand-dependent neural representation of odor information in the olfactory bulb and posterior piriform cortex. J Neurosci. 2019;39:10002–18.
Wu H, Yan X, Tang D, Gu W, Luan Y, Cai H, et al. Internal states influence the representation and modulation of food intake by subthalamic neurons. Neurosci Bull. 2020;36:1355–68.
Huang YK, Lu YG, Zhao X, Zhang JB, Zhang FM, Chen Y, et al. Cytokine activin C ameliorates chronic neuropathic pain in peripheral nerve injury rodents by modulating the TRPV1 channel. Br J Pharmacol. 2020;177:5642–57.
Zhou C, Luo ZD. Nerve injury-induced calcium channel α2δ1 protein dysregulation leads to increased pre-synaptic excitatory input into deep dorsal horn neurons and neuropathic allodynia. Eur J Pain. 2015;19:1267–76.
Dixon WJ. Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol. 1980;20:441–62.
Treede RD, Meyer RA, Raja SN, Campbell JN. Peripheral and central mechanisms of cutaneous hyperalgesia. Prog Neurobiol. 1992;38:397–421.
Decosterd I, Woolf CJ. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain. 2000;87:149–58.
Zhang H, Qian YL, Li C, Liu D, Wang L, Wang XY, et al. Brain-derived neurotrophic factor in the mesolimbic reward circuitry mediates nociception in chronic neuropathic pain. Biol Psychiatry. 2017;82:608–18.
Wang HR, Hu SW, Zhang S, Song Y, Wang XY, Wang L, et al. KCNQ channels in the mesolimbic reward circuit regulate nociception in chronic pain in mice. Neurosci Bull. 2021;37:597–610.
Zhou C, Gu W, Wu H, Yan X, Deshpande P, Xiao C, et al. Bidirectional dopamine modulation of excitatory and inhibitory synaptic inputs to subthalamic neuron subsets containing α4β2 or α7 nAChRs. Neuropharmacology. 2019;148:220–8.
Fan JP, Geng HZ, Ji YW, Jia T, Treweek JB, Li AA, et al. Age-dependent alterations in key components of the nigrostriatal dopaminergic system and distinct motor phenotypes. Acta Pharmacol Sin. 2022;43:862–75.
Xiao C, Cho JR, Zhou C, Treweek JB, Chan K, McKinney SL, et al. Cholinergic mesopontine signals govern locomotion and reward through dissociable midbrain pathways. Neuron. 2016;90:333–47.
Grace AA, Onn SP. Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro. J Neurosci. 1989;9:3463–81.
Lacey MG, Mercuri NB, North RA. Two cell types in rat substantia nigra zona compacta distinguished by membrane properties and the actions of dopamine and opioids. J Neurosci. 1989;9:1233–41.
Benarroch EE. Pedunculopontine nucleus: functional organization and clinical implications. Neurology. 2013;80:1148–55.
Mena-Segovia J, Bolam JP. Rethinking the pedunculopontine nucleus: from cellular organization to function. Neuron. 2017;94:7–18.
Xiao C, Miwa JM, Henderson BJ, Wang Y, Deshpande P, McKinney SL, et al. Nicotinic receptor subtype-selective circuit patterns in the subthalamic nucleus. J Neurosci. 2015;35:3734–46.
Jing M, Li Y, Zeng J, Huang P, Skirzewski M, Kljakic O, et al. An optimized acetylcholine sensor for monitoring in vivo cholinergic activity. Nat Methods. 2020;17:1139–46.
Jing M, Zhang P, Wang G, Feng J, Mesik L, Zeng J, et al. A genetically encoded fluorescent acetylcholine indicator for in vitro and in vivo studies. Nat Biotechnol. 2018;36:726–37.
Carstens E, Carstens MI. Sensory effects of nicotine and tobacco. Nicotine Tob Res. 2022;24:306–15.
Liu D, Tang QQ, Wang D, Song SP, Yang XN, Hu SW, et al. Mesocortical BDNF signaling mediates antidepressive-like effects of lithium. Neuropsychopharmacology. 2020;45:1557–66.
Liu D, Tang QQ, Yin C, Song Y, Liu Y, Yang JX, et al. Brain-derived neurotrophic factor-mediated projection-specific regulation of depressive-like and nociceptive behaviors in the mesolimbic reward circuitry. Pain. 2018;159:175.
Lester HA, Xiao C, Srinivasan R, Son CD, Miwa J, Pantoja R, et al. Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery. AAPS J. 2009;11:167–77.
Nashmi R, Lester H. Cell autonomy, receptor autonomy, and thermodynamics in nicotine receptor up-regulation. Biochem Pharmacol. 2007;74:1145–54.
Acknowledgements
This work was supported by the National Natural Science Foundation of China (82071231 (CX), 81971038 (CYZ), 82171235 (CYZ), 82271293 (CX), 82371242 (CYZ)), the Fund for Jiangsu Province Specially Appointed Professor (CX, CYZ), the Natural Science Foundation of Jiangsu Province (BK20211349, CYZ), the Natural Science Foundation of the Jiangsu Higher Education Institutions of China (23KJA320006 (CYZ), 23KJA320007, (CX)), and the Leadership Program in Xuzhou Medical University (JBGS202203, CX). We thank Terrence Z.Y. Xiao for data organization and grammar check for the manuscript.
Author information
Authors and Affiliations
Contributions
CX, CYZ and SL designed the experiments. CX and CYZ supervised this research. YH, JQZ, YWL and YJ performed mouse survival surgeries and morphological experiments. YH, JQZ, SYL, YWL, CY and YJ performed behavioral tests and managed the mouse colony. YWJ and HZG collected and analyzed electrophysiological data. CX, CYZ and YH wrote the manuscript. All authors read and approved the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Supplementary Information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Han, Y., Zhang, Jq., Ji, Yw. et al. α4 nicotinic receptors on GABAergic neurons mediate a cholinergic analgesic circuit in the substantia nigra pars reticulata. Acta Pharmacol Sin (2024). https://doi.org/10.1038/s41401-024-01234-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41401-024-01234-7